Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...

High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

Expert Rev Clin Pharmacol. 2012;5(3):319-336. Aspirin improves clinical outcome in all cardiovascular (CV) syndromes in primary and secondary prevention, including acute events. In high-risk ...

Expert Rev Clin Pharmacol. 2012;5(3):319-336. †There are controversial data concerning prasugrel resistance, and there is a need for larger studies to confirm prasugrel resistance. IPA ...